Press Releases September 25, 2026 09:00 AM

SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026

SBC Medical to Present at Multiple Investor Conferences in October 2026

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
SBC

SBC Medical Group Holdings, a Nasdaq-listed Medical Services Organization, announced its participation in several notable investor conferences in October 2026, aiming to engage institutional investors and present its growth strategies. The company continues to expand its global footprint in various healthcare specialties and maintain its position in the Russell 3000 Index.

SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
SBC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • SBC Medical will participate in three major investor conferences in October 2026, including virtual and in-person events in New York.
  • The company manages a diverse portfolio of healthcare clinic brands across multiple specialties such as dermatology, orthopedics, fertility treatment, and more.
  • SBC Medical is expanding its presence internationally, particularly in the U.S. and Asia, through direct operations and medical tourism initiatives.

IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in October 2026. SBC Medical will conduct presentations and one-on-one meetings with institutional investors.

Below is a summary of the Company's scheduled participation in upcoming investor conferences:

Noble Capital Markets October 2026 Emerging Growth Virtual Equity Conference
Date: October 1-2, 2026
Format: Virtual
Registration: Link

Maxim Growth Summit 2026
Date: October 14, 2026
Format: In-person (New York)
Registration: Link

The ThinkEquity Conference 2026
Date: October 15, 2026
Format: In-person (New York)
Registration: Link

About SBC Medical Group Holdings Incorporated

SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, Hair Loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com

For more insights and updates from SBC Medical, follow us on LinkedIn

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC's website at www.sec.gov.

Contacts

Hikaru Fukui
Head of IR Department
E-mail: [email protected]


Risks

  • Forward-looking statements highlight uncertainties including economic, regulatory, and competitive factors that could impact performance.
  • Risks of relying on future growth expectations amid changing global and local market conditions.
  • Potential for changes in healthcare industry regulations and market dynamics affecting expansion plans.

More from Press Releases

Banco Santander Chile: Third Quarter 2026 Analyst and Investor Webcast / Conference Call Sep 25, 2026 Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026 Sep 25, 2026 INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference Sep 25, 2026 Tilray Brands to Announce First Quarter Fiscal Year 2027 Financial Results on October 8, 2026 Sep 25, 2026 Kodiak AI Names Dallas-Houston As Long-Haul Driverless Launch Lane, Consistently Completes Intervention-Free, End-to-End Deliveries Sep 25, 2026